323
Views
9
CrossRef citations to date
0
Altmetric
Review

Alirocumab for the treatment of hyperlipidemia in high-risk patients: an updated review

Pages 923-932 | Received 28 Sep 2017, Accepted 21 Nov 2017, Published online: 30 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Etienne Khoury, Diane Brisson & Daniel Gaudet. (2020) Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia. Expert Opinion on Drug Discovery 15:4, pages 403-414.
Read now

Articles from other publishers (8)

A. A. Nekipelova & R. N. Alyautdin. (2023) PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines. Safety and Risk of Pharmacotherapy 11:3, pages 279-291.
Crossref
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz & Beata Franczyk. (2023) Advances in Treatment of Dyslipidemia. International Journal of Molecular Sciences 24:17, pages 13288.
Crossref
Liang ChenHao PengBo-Lin Wang, Wen-Yuan Yu, Xiao-Hang Ding, Ming-Xin Gao & Yang Yu. (2023) Trends and hotspots in familial hypercholesterolemia: A bibliometric systematic review from 2002 to 2022. Medicine 102:28, pages e34247.
Crossref
Yuanbojiao Zuo, Chen Zhang, Yuan Zhou, Haiwen Li, Weidong Xiao, Roland W. Herzog, Jie Xu, Jifeng Zhang, Y. Eugene Chen & Renzhi Han. (2023) Liver-specific in vivo base editing of Angptl3 via AAV delivery efficiently lowers blood lipid levels in mice. Cell & Bioscience 13:1.
Crossref
Toufik Abdul-Rahman, Syed Muhammad Awais Bukhari, Emiliano Cantu Herrera, Wireko Andrew Awuah, Jannel Lawrence, Heloisa de Andrade, Neal Patel, Rohan Shah, Raheel Shaikh, Camilo Andrés Avendaño Capriles, Sebahat Ulusan, Shahzaib Ahmad, Anna Chiara Corriero, Adriana C. Mares, Akshay Goel, Adrija Hajra, Dhrubajyoti Bandyopadhyay & Rahul Gupta. (2022) Lipid Lowering Therapy: An Era Beyond Statins. Current Problems in Cardiology 47:12, pages 101342.
Crossref
Ramla Shabbir, Muhammad Nasir Hayat Malik, Maryam Zaib, Alamgeer, Shah Jahan & Muhammad Tariq Khan. (2022) Amino Acid Conjugates of 2-Mercaptobenzimidazole Ameliorates High-Fat Diet-Induced Hyperlipidemia in Rats via Attenuation of HMGCR, APOB, and PCSK9. ACS Omega 7:44, pages 40502-40511.
Crossref
Jie Wang, Yun-Shan Wang, Ya-Ping Huang, Cui-Hua Jiang, Meng Gao, Xian Zheng, Zhi-Qi Yin & Jian Zhang. (2021) Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression. Phytomedicine 91, pages 153688.
Crossref
Xiaoding Xu, Yunxia Dong, Ningning Ma, Weiwen Kong, Chuwei Yu, Likun Gong, Jing Chen & Jin Ren. (2021) MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice. Metabolism 119, pages 154768.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.